

Performance Improvement 2001. Assess Programs to Prevent Diabetic End-Stage Renal Disease
Diabetic end-stage renal disease (ESRD) is a serious and costly complication of diabetes. Renal protective benefits have been demonstrated for angiotensin converting enzyme (ACE) inhibitors, leaning the American Diabetes Association (ADA) to recommend that patients receive treatment with ACE inhibitors after the onset of microalbuminuria.